Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
Price: $0.87 | Change: +$0.07 | %Change: +8.75%
Volume: 284,267 | Day High/Low: 0.91/0.80 | 52 Week High/Low: 2.89/0.445

Snapshot

Last Traded: October 30, 2014 09:42 Transaction Volume: 284,267
Open: $0.87 Previous Close: $0.80
Bid: $0.88 Ask: $0.90
Bid Size: 4,000 Ask Size: 3,500
Market Cap: $77.9m Shares Out: 89.6m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Latest Bullboard Posts

  • Wow - Feeling better

    0 stars

    Something is up. Thought of doubling - up a while back @ 0.50 and didnt.  Oh well.

    2.5 stars


  • RE:What is going on?

    0 stars

    KETZA wrote: Not even 1pm  ONCY @ 5x average volume and ONC @ twice the average volume. SP up 26% and no company news. Strange .....very...

    2.5 stars


  • RE:What is going on?

    0 stars

    I could be wrong but it looks like a takeover is coming up.

    2 stars


  • What is going on?

    0 stars

    Not even 1pm  ONCY @ 5x average volume and ONC @ twice the average volume. SP up 26% and no company news. Strange .....very strange.

    2 stars


  • Are We Entering The Final Stage?

    5 stars

    Is this end? Will Oncolytics crash and burn? The late stage development company is risking everything on Reolysin. The market is trading...

    1.5 stars